Editor, Scrip & Pink Sheet, covering pharmaceutical and business news and analysis; views expressed are purely my own.

Read Full Bio →


Eleanor has been Editor of Scrip Intelligence since 2014. She has worked on the title since 2000, reporting and analysing all aspects of the global pharma industry from M&A and partnering, financial and strategy news and trends through R&D to market access, policy and regulation. She has ...

Search Tweets

Twitter Feed

@ScripEleanor — 1,815 followers, 2,721 tweets

May 23, 2017

RT @ScripIanS: MSD's discount scheme for Remicade may have broken competition law by limiting #biosimilar competition, says UK CMA  http://bit.ly/2rLmpEr 

May 19, 2017

Wow. EMA has just announced 3 negative opinions on drugs for approval (inc anamorelin, masitinib). First this year. https://t.co/AyQfs5fedI https://t.co/L05KPriObm

Show more